Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5107)
All Articles published online
|
Publishing Process of This Article
|
Jun 24, 2016 (publication date) through May 13, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Transplantation
ISSN
2220-3230
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Brioli A. First line vs delayed transplantation in myeloma: Certainties and controversies. World J Transplant 2016; 6(2): 321-330 [PMID: 27358777 DOI: 10.5500/wjt.v6.i2.321] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v6/i2/321.htm |
| Number | Citing Articles |
| 1 |
Ursina Gössi, Barbara Jeker, Behrouz Mansouri Taleghani, Ulrike Bacher, Urban Novak, Daniel Betticher, Thomas Egger, Thilo Zander, Thomas Pabst. Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograft. Hematological Oncology 2018; 36(2): 436 doi: 10.1002/hon.2490
|
| 2 |
Ankit Kansagra, Wilson I. Gonsalves, Morie A. Gertz, Francis K. Buadi, David Dingli, Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman, Prashant Kapoor, Eli Muchtar, Taxiarchis V. Kourelis, Rahma Warsame, Nelson Leung, Steven R. Zeldenrust, John A. Lust, S. Vincent Rajkumar, Robert A. Kyle, William Hogan, Shaji K. Kumar. Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple Myeloma. Biology of Blood and Marrow Transplantation 2018; 24(10): 2127 doi: 10.1016/j.bbmt.2018.04.007
|
| 3 |
Selina J. Chavda, Paul M. Maciocia, Pavlina Mesiri, Nicholas Counsell, Jaimal Kothari, Antonia Bird, Ciaran Mariner, Anastasia Chew, Katherine Clesham, Sally Moore, Laura Percy, Ali Rismani, Shirley D'Sa, Neil Rabin, Rakesh Popat, Kwee Yong. A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1. British Journal of Haematology 2019; 185(2): 350 doi: 10.1111/bjh.15487
|
| 4 |
|
| 5 |
Weerapat Owattanapanich, Kittima Suphadirekkul, Chutima Kunacheewa, Patompong Ungprasert, Kannadit Prayongratana. Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-5054-6
|
| 6 |
Lalit Kumar, Mohammad Mir Hussain, Rajegowda Chethan, Ranjit Kumar Sahoo, Prabhat S. Malik, Om Dutt Sharma, Anisha Mathew, Ankit Jha, Ritu Gupta, Atul Sharma, Ahitagni Biswas, Rakesh Kumar, Sanjay Thulkar, Soumyaranjan Malik, Ashish Dutt. Multiple Myeloma: Impact of Time to Transplant on the Outcome. Clinical Lymphoma Myeloma and Leukemia 2022; 22(9): e826 doi: 10.1016/j.clml.2022.04.020
|
| 7 |
Monica Epstein, Candis Morrison. Practical guidance for new multiple myeloma treatment regimens: A nursing perspective. Seminars in Oncology 2022; 49(1): 103 doi: 10.1053/j.seminoncol.2022.01.010
|
| 8 |
Mia Cahill. The Pivotal Role of Proteasome Inhibition in Myeloma Treatment. EMJ Hematology 2017; : 2 doi: 10.33590/emjhematol/10314234
|